Product sales
Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, vaccines and consumer health products.
Read more about the 2012 sales of our top 20 pharmaceutical products in the table below.
For more information, visit our products section
| Product | Full Year 2012 Product Sales | Business franchise | |
|---|---|---|---|
| USD m | % change (USD) | ||
 |
4,675 | 0% | Oncology |
 |
4,417 | -22% | Primary care |
 |
2,398 | 17% | Ophthalmics |
 |
1,512 | 5% | Oncology |
 |
1,352 | 12% | Primary care |
 |
1,288 | -13% | Oncology |
 |
1,195 | 142% | Neuroscience |
 |
1,050 | -2% | Neuroscience |
 |
998 | 39% | Oncology |
 |
910 | 34% | Primary care |
 |
870 | 2% | Oncology |
 |
821 | -9% | Integrated Hospital Care |
 |
797 | 80% | Oncology |
 |
759 (excl. OTC) | -4% | Additional products |
 |
590 | -4% | Established medicines |
 |
579 | 12% | Integrated Hospital Care |
 |
554 | 1% | Additional products |
 |
530 | -14% | Neuroscience |
 |
504 | 5% | Critical Care |
 |
438 | -52% | Oncology |
